Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$817K Buy
2,255
+641
+40% +$219K 0.13% 156
2026
Q1
$568K Sell
1,614
-79
-5% -$28.2K 0.13% 153
2025
Q4
$554K Sell
1,693
-14
-0.8% -$4.44K 0.13% 146
2025
Q3
$482K Sell
1,707
-7
-0.4% -$2.03K 0.1% 155
2025
Q2
$479K Buy
1,714
+45
+3% +$12.7K 0.12% 160
2025
Q1
$519K Buy
1,669
+96
+6% +$28.3K 0.14% 132
2024
Q4
$410K Buy
+1,573
New +$467K 0.1% 158

Other funds holding AMGN

PKS Advisory Services's AMGN Position: Q2 2026 in Review

PKS Advisory Services increased its Amgen (AMGN) stake by 40% in Q2 2026, buying an estimated $219K and bringing the position to 2,255 shares worth $817K. The position accounts for 0.13% of the portfolio, ranked #156.

PKS Advisory Services first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • PKS Advisory Services held 2,255 shares of Amgen worth $817K as of Q2 2026.
  • PKS Advisory Services bought 641 Amgen shares in Q2 2026, an estimated $219K.
  • Amgen made up 0.13% of PKS Advisory Services's portfolio in Q2 2026, its #156 holding.
  • PKS Advisory Services first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on PKS Advisory Services's 13F filing for Q2 2026, filed 4 Aug 2026.